Interleukin-10 (IL-10) is known to be a tolerogenic cytokine since it inhibits pro-inflammatory cytokine production and T cell stimulatory capacities of myeloid cells, such as macrophages and dendritic cells. In particular, it has a non-redundant tolerogenic role in intestinal immune homeostasis, since mice and patients with genetic defects in the IL-10/IL-10R pathway develop spontaneously colitis in the presence of a normal intestinal flora. However, IL-10 is also a growth and differentiation factor for B-cells, can promote autoantibody production and has consequently a pathogenic role in systemic lupus erythematosus. Moreover, IL-10 can promote cytotoxic T-cell (CTL) responses and this immunogenic activity might be relevant in type-1 diabetes and anti-tumor immune responses. This review summarizes these paradoxic effects of IL-10 on different types of immune responses, and proposes that different cellular sources of IL-10, in particular IL-10-secreting helper and regulatory T-cells, have different effects on B-cell and CTL responses. Based on this concept we discuss the rationales for targeting the IL-10 pathway in immune-mediated diseases and cancer.

The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer / J. Geginat, P. Larghi, M. Paroni, G. Nizzoli, A. Penatti, M. Pagani, N. Gagliani, P. Meroni, S. Abrignani, R.A. Flavell. - In: CYTOKINE & GROWTH FACTOR REVIEWS. - ISSN 1359-6101. - (2016). [Epub ahead of print] [10.1016/j.cytogfr.2016.02.003]

The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer

J. Geginat;M. Paroni;M. Pagani;P. Meroni;S. Abrignani
Penultimo
;
2016

Abstract

Interleukin-10 (IL-10) is known to be a tolerogenic cytokine since it inhibits pro-inflammatory cytokine production and T cell stimulatory capacities of myeloid cells, such as macrophages and dendritic cells. In particular, it has a non-redundant tolerogenic role in intestinal immune homeostasis, since mice and patients with genetic defects in the IL-10/IL-10R pathway develop spontaneously colitis in the presence of a normal intestinal flora. However, IL-10 is also a growth and differentiation factor for B-cells, can promote autoantibody production and has consequently a pathogenic role in systemic lupus erythematosus. Moreover, IL-10 can promote cytotoxic T-cell (CTL) responses and this immunogenic activity might be relevant in type-1 diabetes and anti-tumor immune responses. This review summarizes these paradoxic effects of IL-10 on different types of immune responses, and proposes that different cellular sources of IL-10, in particular IL-10-secreting helper and regulatory T-cells, have different effects on B-cell and CTL responses. Based on this concept we discuss the rationales for targeting the IL-10 pathway in immune-mediated diseases and cancer.
English
Cancer; Colitis; Interleukin-10; Systemic lupus erythematosus; T-cells
Settore BIO/11 - Biologia Molecolare
Articolo
Esperti anonimi
Pubblicazione scientifica
2016
Elsevier Ltd
Epub ahead of print
Periodico con rilevanza internazionale
scopus
pubmed
crossref
Aderisco
info:eu-repo/semantics/article
The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer / J. Geginat, P. Larghi, M. Paroni, G. Nizzoli, A. Penatti, M. Pagani, N. Gagliani, P. Meroni, S. Abrignani, R.A. Flavell. - In: CYTOKINE & GROWTH FACTOR REVIEWS. - ISSN 1359-6101. - (2016). [Epub ahead of print] [10.1016/j.cytogfr.2016.02.003]
reserved
Prodotti della ricerca::01 - Articolo su periodico
10
262
Article (author)
no
J. Geginat, P. Larghi, M. Paroni, G. Nizzoli, A. Penatti, M. Pagani, N. Gagliani, P. Meroni, S. Abrignani, R.A. Flavell
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1359610116300193-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.45 MB
Formato Adobe PDF
1.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/372359
Citazioni
  • ???jsp.display-item.citation.pmc??? 40
  • Scopus 98
  • ???jsp.display-item.citation.isi??? 86
social impact